Hotel Dieu Hospital
Kingston, Ontario, K7L 5G2, Canada
NCT Number: NCT00885274
Pico-Salax is an osmotic and stimulant bowel cleansing agent used prior to colonoscopy. It is unknown whether splitting the doses (i.e. taking the second dose the morning of the colonoscopy) results in a better bowel cleansing, as research with other agents suggests this may be the case. This study aims to assess whether splitting the dose of Pico-Salax results in a better bowel cleansing than traditional dosing.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Kingston, Ontario, K7L 5G2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Both doses of Pico-Salax taken the evening prior to colonoscopy
One dose of Pico-Salax taken the evening prior to colonoscopy and the other the morning of the procedure.
Time frame: day of colonoscopy
Time frame: day of colonoscopy
Queen's University
Other
A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06763705
Colonoscopy, Conscious Sedation
Unaizah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT06407531
Colonoscopy
Antalya, Finike, Turkey (Türkiye)
View Trial DetailsNCT04921488
Colonic Diseases, Colonoscopy
Angers, France
View Trial DetailsNCT07590869
Anxiety, Anxiety Disorders
Malatya, Turkey (Türkiye)
View Trial Details